The AUA National Urology Research Agenda (NURA) serves as a roadmap for articulating the basic and clinical research and research infrastructure priorities in urology, thereby promoting substantial improvements in patient care. The NURA identifies gaps in knowledge and communicates urology research needs to key constituents at the federal level. It emphasizes the importance of multidisciplinary activities and defines areas of potential. This is critical to "growing" the field and to increasing competitiveness for funding.
The NURA program identifies major priorities in the following disease areas that need to be addressed in order to advance progress in urology research:
- Benign Prostatic Hyperplasia
- Bladder Cancer
- Chronic Pelvic Pain/Prostatitis/Interstitial Cystitis/Bladder Pain Syndrome
- Developmental Anomalies
- Male Reproduction and Infertility
- Prostate Cancer
- Renal Cell Carcinoma
- Sexual Dysfunction
- Urinary Incontinence/Overactive Bladder/Neurogenic Bladder
- Urinary Tract Infections
Since its inception, the NURA has been considered a "living" document. It will be subjected to a review and revision process to ensure that it remains current and responsive to progress and evolving trends. The NURA will be implemented through a series of clear, concise and compelling messages intended to be used as targeted tools that will allow the research, clinical and advocacy communities to realize the goal of increasing awareness, research activity and funding in urology research.
Access the National Urology Research Agenda [pdf]